Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,...
Reexamination Certificate
2007-12-21
2010-11-16
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
C530S308000, C530S387100, C514S002600
Reexamination Certificate
active
07833531
ABSTRACT:
The present invention provides to at least one novel human GLP-1 receptor agonist, or specified portion or variant, including isolated nucleic acids that encode at least one GLP-1 receptor agonist, or specified portion or variant, GLP-1 receptor agonist, or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including the use of long acting GLP-1 receptor agonists to improve insulin sensitivity or lipid profiles in obesity and related therapeutic and/or diagnostic compositions, methods and devices.
REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4239754 (1980-12-01), Sache et al.
patent: 4309989 (1982-01-01), Fahim
patent: 4399216 (1983-08-01), Axel et al.
patent: 4634665 (1987-01-01), Axel et al.
patent: 4656134 (1987-04-01), Ringold
patent: 4668218 (1987-05-01), Virtanen
patent: 4767402 (1988-08-01), Kost et al.
patent: 4873316 (1989-10-01), Meade et al.
patent: 4925673 (1990-05-01), Steiner et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4956288 (1990-09-01), Barsoum
patent: 5118666 (1992-06-01), Habener
patent: 5122464 (1992-06-01), Wilson et al.
patent: 5149636 (1992-09-01), Axel et al.
patent: 5179017 (1993-01-01), Axel et al.
patent: 5266491 (1993-11-01), Nagata et al.
patent: 5304489 (1994-04-01), Rosen
patent: 5404871 (1995-04-01), Goodman et al.
patent: 5458135 (1995-10-01), Patton et al.
patent: 5514670 (1996-05-01), Friedman et al.
patent: 5545618 (1996-08-01), Buckley et al.
patent: 5565362 (1996-10-01), Rosen
patent: 5770222 (1998-06-01), Unger et al.
patent: 5770359 (1998-06-01), Wilson et al.
patent: 5827690 (1998-10-01), Meade et al.
patent: 5827739 (1998-10-01), Wilson et al.
patent: 5839446 (1998-11-01), Waner et al.
patent: 5849695 (1998-12-01), Cohen et al.
patent: 5849992 (1998-12-01), Meade et al.
patent: 5851198 (1998-12-01), Castellano et al.
patent: 5871753 (1999-02-01), Crabtree et al.
patent: 5879681 (1999-03-01), Leone-Bay et al.
patent: 5977071 (1999-11-01), Galloway et al.
patent: 5994616 (1999-11-01), Rosen
patent: 6730690 (2004-05-01), Olson et al.
patent: 237507 (1987-09-01), None
patent: WO 92/16221 (1992-10-01), None
patent: WO 94/06498 (1994-03-01), None
patent: WO 94/08552 (1994-04-01), None
patent: WO 94/16970 (1994-08-01), None
patent: WO 97/22376 (1997-06-01), None
patent: WO 97/25086 (1997-07-01), None
patent: WO 98/35888 (1998-08-01), None
patent: WO 98/53847 (1998-12-01), None
patent: WO 01/66135 (2001-09-01), None
patent: WO 2005/005604 (2005-01-01), None
patent: WO 2005/097175 (2005-10-01), None
patent: WO 2007/046834 (2007-04-01), None
patent: WO 2007/076319 (2007-07-01), None
patent: WO 2007/081302 (2007-07-01), None
Wells, Biochemistry 29:8509-8517, 1990.
The Merck Manual, 17th ed., Merck Research Laboratories, Merck and Co., Whitehouse Station, NJ (1999).
Sarmay et al. Molec. Immunol. 29 (5): 633-9 (1992).
Adelhorst, et al.,J. Biol. Chem. 269:6275 (1994).
Elliott et al.,Lancet344:1125-1127 (1994).
Ausubel, et al., ed., Current Protocols in Molecular Biology, John Wiley & Sons, Inc., NY, NY (1987-2005).
Sambrook, et al., Molecular Cloning: A Laboratory Manual, 2ndEdition, Cold Spring Harbor, NY (1989).
Harlow and Lane, Antibodies, a Laboratory Manual, Cold Spring Harbor, NY (1989).
Colligan, et al., eds., Current Protocols in Immunology, John Wiley & Sons, Inc., NY (1994-2005).
Colligan et al., Current Protocols in Protein Science, John Wiley & Sons, NY, NY, (1997-2005).
Bird, R.E. et al.,Science, 242: 423-426 (1988).
Cramer et al., Curr. Top. Microbol. Immunol. 240:95-118 (1999).
Hood et al., Adv. Exp. Med. Biol. 464:127-147 (1999).
Conrad et al., Plant Mol. Biol. 38:101-109 (1998).
Fischer et al., Biotechnol. Appl. Biochem. 30:99-108 (Oct. 1999).
Ma et al., Trends Biotechnol. 13:522-7 (1995).
Ma et al., Plant Physiol. 109:341-6 (1995).
Whitelam et al., Biochem. Soc. Trans. 22:940-944 (1994).
Berzofsky, et al., “Antibody-Antigen Interactions,”In Fundamental Immunology, Paul, W. E., Ed., Raven Press: New York, NY (1984).
Kuby, JanisImmunology, W. H. Freeman and Company: New York, NY (1992).
Sprague, et al., J. Virol. 45:773-781 (1983).
Katsube, Y., et al.,Int J Mol. Med, 1(5):863-868 (1998).
Alberts, B., et al., Molecular Biology of The Cell, Third Ed., Garland Publishing, Inc., New York, 1994.
Cunningham and Wells, Science 244:1081-1085 (1989).
Smith, et al., J. Mol. Biol. 224:899-904 (1992).
de Vos, et al., Science 255:306-312 (1992).
Hermanson, G. T.,Bioconjugate Techniques, Academic Press: San Diego, CA (1996).
Fisch et al.,Bioconjugate Chem., 3:147-153 (1992).
Werlen et al.,Bioconjugate Chem., 5:411-417 (1994).
Kumaran et al.,Protein Sci. 6(10):2233-2241 (1997).
Itoh et al.,Bioorg. Chem., 24(1): 59-68 (1996).
Capellas et al.,Biotechnol. Bioeng., 56(4):456-463 (1997).
Nursing 2001 Handbook of Drugs, 21stedition, Springhouse Corp., Springhouse, PA, 2001.
Health Professional's Drug Guide 2001, ed., Shannon, Wilson, Stang, Prentice-Hall, Inc, Upper Saddle River, NJ.
Gennaro, Ed.,Remington's Pharmaceutical Sciences, 18thEdition, Mack Publishing Co. (Easton, PA) 1990.
“Remington: The Science & Practice of Pharmacy”, 19thed., Williams & Williams, (1995).
“Physician's Desk Reference”, 52nded., Medical Economics, Montvale, NJ (1998).
Merck Manual, 12th-17th Editions, Merck & Company, Rahway, NJ (1972, 1977, 1982, 1987, 1992, 1999), Pharmacotherapy Handbook, Wells et al., eds., Second Edition, Appleton and Lange, Stamford, Conn. (1998, 2001).
Wells et al., eds., Pharmacotherapy Handbook, 2ndEdition, Appleton and Lange, Stamford, CT (2000).
PDR Pharmacopoeia, Tarascon Pocket Pharmacopoeia 2000, Deluxe Edition, Tarascon Publishing, Loma Linda, CA (2000).
Junginger, et al., Visualization of Drug Transport Across Human Skin and the Influence of Penetration Enhancers,Drug Permeation Enhancement, Hsieh, D. S., Eds., pp. 59-90 Marcel Dekker, Inc. New York 1994.
“Sustained and Controlled Release Drug Delivery Systems”, J. R. Robinson ed., Marcel Dekker, Inc., N. Y., 1978.
Murphy, et al., Biochem. J. 227:277-279 (1991).
Bebbington, et al., Bio/Technology 10:169-175 (1992).
Cullen, et al., Molec. Cell. Biol. 5:438-447 (1985).
Boshart, et al., Cell 41:521-530 (1985).
F. W. Alt, et al., J. Biol. Chem. 253:1357-1370 (1978).
J. L. Hamlin and C. Ma, Biochem. et Biophys. Acta 1087(2):107-125 (1990).
M. J. Page and M. A. Sydenham, Biotechnology 9:64-68 (1991).
M. Gossen, and H. Bujard, Proc. Natl. Acad. Sci. USA 89: 5547-5551 (1992).
Sheilds et al, 2001, J. Biol. Chem., vol. 276 (9), 6591-6604.
Parlevliet, T.E., et al. “CNT0736, a noval GLP-1 analogue, ameliorates insulin resistance and reduces VLDL production high-fat-fed C57BI/6 mice”, 67thAnnu Meetin Sci Secc Am Diabetes Assoc (online), Jun. 22, 2007, Retrieved from the Internet: URL:http://integrity.prous.com/integrity/servlet/xm1xs1/pk—ref—list.xml—show—ficha—ref?pref—id=1111353.
Parlevliet, T.E., et al. “CNT0736, a nova GLP-1 analogue, ameliorates insulin resistance and reduces VLDL production high-fat-fed C57B1/6 mice”, 67thAnnu Meetin Sci Secc Am Diabetes Assoc (online), Jun. 22, 2007, Retrieved from the Internet: URL:http://integrity.prous.com/integrity/servlet/xm1xs1/pk—ref—list.xml—show—ficha—ref?p—ref—id=1112933.
Picha et al. “Sustained GLP-1R-dependent control of glucose homeostasis by a GLP-1 mimetibody” Diabetologaia, vol. 50, No. 1 suppl. Sep. 1, 2008, p. S245.
O'Neil Karyn T.
Picha Kristen
Stojanovic-Susulic Vedrana
Baumeister Kirk
Centocor, Inc.
Chandra Gyan
Landsman Robert
LandOfFree
Method for treating insulin sensitivity by long-acting GLP-1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating insulin sensitivity by long-acting GLP-1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating insulin sensitivity by long-acting GLP-1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4250771